INTRODUCTION AND OBJECTIVES: Pain, anxiety and embarrassment are well documented feelings in patients undergoing ambulatory diagnostic cystoscopy.
Peak-end theory suggests that humans' perception of any experience depends mainly on the peak and end of that experience regardless of its duration. This theory has been utilized in many applications to improve perception of different experiences, but it has never been studied at the office based urological setting.
In this study, we explored utilizing Peak-end theory in improving pain perception in patients undergoing diagnostic cystoscopy. We hypothesized that if we created a less unpleasant ending of the cystoscopy procedure by leaving the scope for 2 minutes without any manipulation at the end, this will improve patient's pain and anxiety perception after cystoscopy.
METHODS: We conducted a randomized clinical trial for patients undergoing an ambulatory flexible diagnostic cystoscopy for the first time. Males to females as well as arm-allocation ratios were 1:1. Control arm received a standard cystoscopy. Cystoscopies that included endourological interventions were excluded.
In the intervention arm the cystoscope was left in the bladder for additional 2 minutes without further manipulation before scope removal. Pain and anxiety scores after cystoscopy were assessed using Visual Analogue Scale (VAS).
RESULTS: We present the results of 54 patients out of 61 patients recruited so far after exclusion of 7 patients. Baseline characteristics were balanced between the two arms. Mean VAS scores were lower in the intervention arm but not statistically significant (17.2 mm vs. 12.0 P[0.30). VAS scores were also lower in the intervention arm in the females' subgroup (8.1 vs 9.6) (P[0.73) and in the males' subgroup (16.1 vs 23.2) (P[0.36).
Post-cystoscopy anxiety scores were lower in the intervention arm (1.1 vs. 2.3)(P[ 0.024). In gender stratified subgroup analysis, anxiety scores were significantly lower only in the males subgroup (0.96 vs 3.4) ( P[0.013). In females subgroup, intervention arm showed lower scores but this was not statistically significant (0.92 vs 1.0) (P[0.90).
CONCLUSIONS: Our study represents the first assessment of Peak-end theory in the office based urological setting.
Utilizing the tenets of the Peak-end theory, by making the endphase of an unpleasant procedure like diagnostic cystoscopy less unpleasant, showed promising improvement in post-procedure pain and anxiety perception scores.
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Adrian Sosenko*, Thomas Lanchoney, Hershey, PA; Thomas Guzzo, Edouard Trabulsi, Philadelphia, PA; John Danella, Heshey, PA; Mark Mann, Adam Reese, Philadelphia, PA; Jeffrey Tomaszewski, Hershey, PA; Serge Ginzburg, Philadelphia, PA; Robert Uzzo, Marc Smaldone, Claudette Fonshell, Bret Marlowe, Jay Raman, Adrian Sosenko, Hershey, PA INTRODUCTION AND OBJECTIVES: Transrectal ultrasound guided prostate needle biopsy (TRUS PNB) is associated with infectious complications due to antibiotic resistant organisms. Prophylaxis regimens have evolved to prevent such infections although lack of standardization and heterogeneity may compound this issue further. We review antibiotic prophylaxis practice patterns for TRUS PNB with a focus on the extent of heterogeneity and consolidation of regimens following a physician champion effort.
METHODS: The Pennsylvania Urologic Regional Collaboration (PURC) is a physician-led quality collaborative established in 2015 with 9 participating practices encompassing 108 urologists. Amongst biopsies performed from 2015-2017, 5379 had documentation of prophylactic antibiotic regimen and formed the cohort of analysis. Overall number and distribution of antibiotic regimens were determined. Quarterly trends in the number of unique antibiotic regimens were noted.
RESULTS: Of the 5379 TRUS PNB cases, 4147 (77%) utilized a single agent, 1197 (22%) used dual augmented therapy, and 35(1%) incorporated three or more antibiotics for prophylaxis. To date, 88 unique antibiotic regimens were used for prophylaxis with the 10 most common noted in Figure 1 . Ciprofloxacin (n[2609, 48%) and Ceftriaxone (n[2268, 42%) were most often used either alone or in combination with other agents. The number of unique antibiotic combinations increased quarterly from Q2 2015 (n[18 regimens) to Q2 2017 (n[40 regimens). A physician champion led effort to standardize regimens based on guidelines and local antibiograms resulted in a 43% reduction in unique regimens (Q4 2017; n[23 regimens). (Figure 2) CONCLUSIONS: Significant variability exists with respect to prophylactic antibiotic regimens across providers in PURC. However, proactive guidelines based education was successful in consolidating protocols. Future evaluation is requisite to determine sustainability of such efforts.
